PCOL of Psoriasis (Maize) Flashcards
Psoriasis is a disease characterized by keratinocyte ____ and incomplete ____ caused by cytokines (IL-1 & TNFa) released from infiltrating activated T-cells.
Evidence points to an ____-mediated disorder, possibly an organ-specific ____ ____ of skin.
hyperproliferation and incomplete differentiation
immune;autoimmune disease
Cytotoxic Agents – Coal tar
MOA:
- Suppresses ____ synthesis which ____ epithelial cell proliferation
- ____ agent
- DNA; decreases
- Photosensitizing
Cytotoxic Agents - Coal tar Side Effects: - Irritation, stinging, burning (\_\_\_\_ smarts) - Folliculitis (bumps around hair follicles) particularly of the axilla and groin (tar acne) - \_\_\_\_ dermatitis - Photosensitizing - Carcinogenic (rare) - No \_\_\_\_ side effects - Will stain light skin and hair - Unpleasant \_\_\_\_
- tar
- contact
- systemic
- odor
Cytotoxic Agents - Shale tar (ichthammol)
- Cytotoxic but the exact mechanism of action is unknown
- No clinical studies have demonstrated its ____, but it is ____ and gives ____ relief
- It is less ____ and has no ____ activity unlike coal tar
- Also used for treatment of ____, ____, and acute ____ ____
- effectiveness; safe; symptomatic
- irritating; photosensitizing
- eczema, rosacea, otitis externa
Cytotoxic Agents - Anthralin
MOA:
____ of the DNA alpha helix by ____ ____
Pharmacological effect
suppresses ____ keratinocyte cell ____
Side effects:
- Local ____, mainly to normal skin
- ____ on normal skin around lesions
- Severe ____ with eye contact
- No ____ side effects
- Will stain skin, hair, clothes a dark brown/black color
MOA:
Disruption, free radicals
Pharmacological effect
hyperplastic; growth
Side effects
- irritation
- erythema
- conjunctivitis
- systemic
T-cell and cytokine suppressors - Methotrexate
MOA:
- Inhibits ____ ____
- Promotes the ____ of activated _-____
Pharmacological effect
- ____ keratinocyte hyperproliferation
- ____ the number of T-cells
Side effects:
- GI: diarrhea, ulcerative stomatitis
- Blood ____ (anemia)
- Cirrhosis (liver scarring)
- Teratogenic
- loss of ____
MOA:
- dihydrofolate reductase
- apoptosis; T-cells
Pharmacological effect
- Reduces
- Reduces
Side effects
- dyscrasias
- hair
T-cell and cytokine suppressors - Mycophenolate mofetil (Myfortic)
MOA:
- Inhibits ____ synthesis
- Inhibits ____ production
Pharmacological effect:
- reduces the number of _-_____
- ____ action
Side effects
- ____ ____ suppression
- GI upset
- ____ symptoms (achy, low grade fever)
MOA:
- purine
- cytokine
Pharm effect:
- T-cells
- Anti-inflammatory
Side effects:
- bone marrow
- flu-like
T-cell and cytokine suppressors - Cyclosporine
MOA:
- Arrests keratinocytes in the __ stage of the cell ____
- Inhibits ____ and ____ of cytokines
Pharmacological effect
- reduces the number of _-_____
- ____ action
Side effects
- ____ after long term use
- ____tension
- ____ hyperplasia (gum overgrowth)
- Multiple drug interactions through ____
MOA:
- G0; cycle
- production and release
Pharmacological effect
- T-cells
- Anti-inflammatory
Side effects:
- nephrotoxicity
- hyper
- gingival
- CYP3A4
Antibody Therapy - T-cell inhibitors
Which drug (MOA):
____ - binds to the antigen on psoriatic plaques preventing T-cells from binding
____ - binds CD 11a to inhibit T-cell activation and migration
- Alefacept (Amevive)
- Efalizumab (Raptiva)
Antibody Therapy - TNFα inhibitors What drugs (3)
bind free TNFα and reduces inflammation
- Etanercept (Enbrel), Adalimumab (Humira), Infliximab (Remicade)
2 Types of Antibody Therapy
T-cell inhibitors
TNFα inhibitors
Antibody Therapy:
Pharmacological effect:
- Reduces the ____ and ____ of the plaques
Side Effects
- ____ reactions: chills, site pain, inflammation
- Serious infections and malignancies
- Blood ____
Pharm effect:
- number and size
Side effects:
- injection
- dyscrasias
Nuclear Receptor Binder - Retinoids
MOA:
- Binds to either ____ or ____ retinoid receptors
- A ____ or ____ is formed which alters DNA transcription (direct)
- A single receptor complex binds ____ ____ to alter DNA transcription (indirect)
- RAR (Retinoic Acid Receptors) or RXR (Retinoid X Receptors)
- homodimer or heterodimer
- transcription factors
Nuclear Receptor Binder - Retinoids
Pharmacological effect:
- ____ proliferation and ____ differentiation of keratinocytes
- Acitretin does not suppress ____ ____ as effectively as the other retinoids
- Reduces; enhances
- sebum production
Nuclear Receptor Binder - Retinoids
Acitretin (Soriatane)
Kinetics:
- Half life is __ hours
- Drug is still ____ in the serum from _ to _ ____ after discontinuation
- 49
- detectable; 1 to 3 years